Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Karavitaki, N, Wass, J
التنسيق:	Conference item
منشور في:	2010

مواد مشابهة

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
حسب: Karavitaki, N, وآخرون
منشور في: (2013)

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
حسب: Karavitaki, N, وآخرون
منشور في: (2013)

A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology
حسب: Emilia Sbardella, وآخرون
منشور في: (2016-10-01)

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
حسب: Youngki Lee, وآخرون
منشور في: (2014-09-01)

Cabergoline therapy for Macroprolactinoma during pregnancy: A case report
حسب: Shahzad Hira, وآخرون
منشور في: (2012-10-01)

The outcome of macroprolactinomas resistant to dopamine agonists
حسب: Coculescu, M, وآخرون
منشور في: (2005)

Efficacy and safety of rapid escalation of cabergoline in comparison to conventional regimen for macroprolactinoma: A prospective, randomized trial
حسب: Ashu Rastogi, وآخرون
منشور في: (2012-01-01)

Clinical Outcome of Invasive Pituitary Prolactinomas Treated with Cabergoline
حسب: Bassam M Flamerz Arkawazi
منشور في: (2020-01-01)

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
حسب: Herring, N, وآخرون
منشور في: (2009)

A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
حسب: Soni, A, وآخرون
منشور في: (2008)

Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
حسب: Lambert, K, وآخرون
منشور في: (2017)

Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
حسب: Lambert, K, وآخرون
منشور في: (2017)

Cabergoline-Induced Pneumocephalus Following Treatment for Giant Invasive Macroprolactinoma Presenting With Spontaneous Cerebrospinal Fluid Rhinorrhea
حسب: Souha S Elabd, وآخرون
منشور في: (2018-02-01)

Cabergoline-induced mania in a patient of pituitary microadenoma
حسب: Satyakam Mohapatra, وآخرون
منشور في: (2017-01-01)

An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
حسب: Ali S. Alzahrani, وآخرون
منشور في: (2023-12-01)

Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
حسب: Reddy, R, وآخرون
منشور في: (2011)

A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma
حسب: Michelle Maher, وآخرون
منشور في: (2018-07-01)

Non-adenomatous pituitary tumours.
حسب: Karavitaki, N, وآخرون
منشور في: (2009)

Diagnosis and management of prolactinomas and non-functioning pituitary adenomas.
حسب: Rogers, A, وآخرون
منشور في: (2014)

Nonfunctioning pituitary adenomas: the Oxford experience.
حسب: Wass, J, وآخرون
منشور في: (2009)

Growth hormone replacement in patients with non-functioning pituitary adenoma treated solely by surgery is not associated with increased risk of tumour recurrence.
حسب: Arnold, J, وآخرون
منشور في: (2008)

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
حسب: Arnold, JR, وآخرون
منشور في: (2009)

The postoperative monitoring of nonfunctioning pituitary adenomas.
حسب: Wass, J, وآخرون
منشور في: (2011)

The postoperative monitoring of nonfunctioning pituitary adenomas
حسب: Wass, J, وآخرون
منشور في: (2011)

Treatment of pituitary tumors: history.
حسب: Thanabalasingham, G, وآخرون
منشور في: (2005)

VISUAL FIELD DEFECTS SECONDARY TO CABERGOLINE USE IN A PATIENT WITH PITUITARY TUMOR
حسب: sylvia andrea araneda, وآخرون
منشور في: (2015-02-01)

Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction
حسب: Pankaj Agrawal, وآخرون
منشور في: (2022-12-01)

Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience
حسب: Guadalupe Vargas-Ortega, وآخرون
منشور في: (2022-07-01)

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline
حسب: Emre Bozkirli, وآخرون
منشور في: (2013-01-01)

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
حسب: Pratibha Singh, وآخرون
منشور في: (2011-01-01)

The modern management of macroprolactinomas.
حسب: Grossman, A
منشور في: (1991)

Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma
حسب: DL Goede, وآخرون
منشور في: (2006-04-01)

Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction
حسب: Tania Sundra, وآخرون
منشور في: (2024-03-01)

Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features.
حسب: Suliman, S, وآخرون
منشور في: (2007)

No link to cardiac valvulopathy was seen in cabergoline treated patients
حسب: K Dharshini, وآخرون
منشور في: (2012-10-01)

MANAGEMENT OF ENDOCRINE DISEASE: Pituitary tumour apoplexy.
حسب: Capatina, C, وآخرون
منشور في: (2014)

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
حسب: Barber, T, وآخرون
منشور في: (2011)

Reply to Commentary on "Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction"
حسب: Pankaj Agrawal, وآخرون
منشور في: (2023-03-01)

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
حسب: Fernandez, A, وآخرون
منشور في: (2010)

Macroprolactinoma in an adolescent female with primary amenorrhoea
حسب: Ning Zhang, وآخرون
منشور في: (2024-12-01)